161 related articles for article (PubMed ID: 1906019)
1. Avoidance of cancellation of potential hyperstimulation cycles by conversion to in vitro fertilization-embryo transfer.
Lessing JB; Amit A; Libal Y; Yovel I; Kogosowski A; Peyser MR
Fertil Steril; 1991 Jul; 56(1):75-8. PubMed ID: 1906019
[TBL] [Abstract][Full Text] [Related]
2. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer.
Sher G; Salem R; Feinman M; Dodge S; Zouves C; Knutzen V
Obstet Gynecol; 1993 Jun; 81(6):1009-11. PubMed ID: 8497341
[TBL] [Abstract][Full Text] [Related]
3. Avoidance of oocyte retrieval on the weekend through the use of scheduled ovarian hyperstimulation for in vitro fertilization and embryo transfer.
Nakagawa K; Yamano S; Senuma M; Myogo K; Yamazaki J; Aono T
Fertil Steril; 1997 Nov; 68(5):787-90. PubMed ID: 9389803
[TBL] [Abstract][Full Text] [Related]
4. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders.
Amit A; Yaron Y; Yovel I; Peyser MR; David MP; Botchan A; Lessing JB
Hum Reprod; 1993 Aug; 8(8):1184-6. PubMed ID: 8408514
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and prognostic variables in the ovarian hyperstimulation syndrome.
Navot D; Relou A; Birkenfeld A; Rabinowitz R; Brzezinski A; Margalioth EJ
Am J Obstet Gynecol; 1988 Jul; 159(1):210-5. PubMed ID: 3134814
[TBL] [Abstract][Full Text] [Related]
6. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy rate and ovarian hyperstimulation after luteal human chorionic gonadotropin in in vitro fertilization stimulated with gonadotropin-releasing hormone analog and menotropins.
Herman A; Ron-El R; Golan A; Raziel A; Soffer Y; Caspi E
Fertil Steril; 1990 Jan; 53(1):92-6. PubMed ID: 2104811
[TBL] [Abstract][Full Text] [Related]
8. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
[TBL] [Abstract][Full Text] [Related]
9. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
[TBL] [Abstract][Full Text] [Related]
10. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy rate in IVF rescue in high responders to human menopausal gonadotropin.
Many A; Azem F; Lessing JB; Yovel I; Yavetz H; Amit A
J Assist Reprod Genet; 1999 Nov; 16(10):520-2. PubMed ID: 10575579
[TBL] [Abstract][Full Text] [Related]
12. The administration of glucocorticoids for the prevention of ovarian hyperstimulation syndrome in in vitro fertilization: a prospective randomized study.
Tan SL; Balen A; el Hussein E; Campbell S; Jacobs HS
Fertil Steril; 1992 Aug; 58(2):378-83. PubMed ID: 1633906
[TBL] [Abstract][Full Text] [Related]
13. Use of buserelin and low-dose human menopausal gonadotropin for in vitro fertilization in women at risk of ovarian hyperstimulation syndrome.
Wada I; Matson PL; Troup SA; Lieberman BA
J Assist Reprod Genet; 1995 Apr; 12(4):252-7. PubMed ID: 7580021
[TBL] [Abstract][Full Text] [Related]
14. 'Prolonged coasting': an effective method for preventing severe ovarian hyperstimulation syndrome in patients undergoing in-vitro fertilization.
Sher G; Zouves C; Feinman M; Maassarani G
Hum Reprod; 1995 Dec; 10(12):3107-9. PubMed ID: 8822423
[TBL] [Abstract][Full Text] [Related]
15. Low serum estradiol concentrations after five days of controlled ovarian hyperstimulation for in vitro fertilization are associated with poor outcome.
Khalaf Y; Taylor A; Braude P
Fertil Steril; 2000 Jul; 74(1):63-6. PubMed ID: 10899498
[TBL] [Abstract][Full Text] [Related]
16. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles.
Lindheim SR; Cohen MA; Chang PL; Sauer MV
J Assist Reprod Genet; 1999 May; 16(5):242-6. PubMed ID: 10335470
[TBL] [Abstract][Full Text] [Related]
17. [Coasting: a response to excessive ovarian stimulation].
Dechaud H; Anahory T; Aligier N; Arnal F; Humeau C; Hédon B
Gynecol Obstet Fertil; 2000 Feb; 28(2):115-9. PubMed ID: 10758585
[TBL] [Abstract][Full Text] [Related]
18. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
[TBL] [Abstract][Full Text] [Related]
20. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
